Drug target Mendelian randomisation: are we really instrumenting drug use?
作者信息
Anderson Emma L, Williams Dylan M
机构信息
Department of Mental Health of Older People, Division of Psychiatry, University College London, London, UK.
MRC Unit for Lifelong Health and Ageing, Population Science & Experimental Medicine, University College London, London, UK.
出版信息
Diabetologia. 2023 Jun;66(6):1156-1158. doi: 10.1007/s00125-023-05875-x. Epub 2023 Feb 16.
Abstract
摘要
相似文献
1
Drug target Mendelian randomisation: are we really instrumenting drug use?药物靶点孟德尔随机化：我们真的在对药物使用进行工具变量设定吗？
Diabetologia. 2023 Jun;66(6):1156-1158. doi: 10.1007/s00125-023-05875-x. Epub 2023 Feb 16.
2
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study.评估二甲双胍靶点降低普通人群阿尔茨海默病风险的疗效和机制：一项孟德尔随机研究。
Diabetologia. 2022 Oct;65(10):1664-1675. doi: 10.1007/s00125-022-05743-0. Epub 2022 Jul 29.
3
Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals.2 型糖尿病与痴呆风险：100 万人的观察性和孟德尔随机化研究。
Epidemiol Psychiatr Sci. 2020 Apr 24;29:e118. doi: 10.1017/S2045796020000347.
4
Drug target Mendelian randomisation: are we really instrumenting drug use? Reply to Anderson EL, Williams DM [letter].药物靶点孟德尔随机化：我们真的在为药物使用设定工具变量吗？对安德森·E·L、威廉姆斯·D·M的回复[信函]
Diabetologia. 2023 Jun;66(6):1159-1161. doi: 10.1007/s00125-023-05892-w. Epub 2023 Mar 10.
5
Glycemic traits and Alzheimer's disease: a Mendelian randomization study.血糖特征与阿尔茨海默病：一项孟德尔随机化研究。
Aging (Albany NY). 2020 Nov 16;12(22):22688-22699. doi: 10.18632/aging.103887.
6
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals.葡萄糖对痴呆风险的影响：115875 个人的孟德尔随机研究。
Diabetologia. 2020 Jun;63(6):1151-1161. doi: 10.1007/s00125-020-05124-5. Epub 2020 Mar 14.
7
A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.一种基于数据驱动的研究体重在多种疾病中作用的方法：英国生物库中基于表型全基因组注册的病例对照研究。
Lancet Digit Health. 2019 Jul;1(3):e116-e126. doi: 10.1016/S2589-7500(19)30028-7. Epub 2019 Jun 27.
8
Association between inflammatory bowel disease and Alzheimer's disease: multivariable and bidirectional Mendelian randomisation analyses.炎症性肠病与阿尔茨海默病之间的关联：多变量和双向孟德尔随机化分析
Gut. 2023 Sep;72(9):1797-1799. doi: 10.1136/gutjnl-2022-327860. Epub 2022 Sep 8.
9
Interpreting the Clinical Implications of Drug-Target Mendelian Randomization Studies.解读药物靶点孟德尔随机化研究的临床意义
J Am Coll Cardiol. 2022 Aug 16;80(7):663-665. doi: 10.1016/j.jacc.2022.06.007.
10
Mendelian randomization study of diabetes and dementia in the Million Veteran Program.百万退伍军人计划中糖尿病与痴呆的孟德尔随机化研究。
Alzheimers Dement. 2023 Oct;19(10):4367-4376. doi: 10.1002/alz.13373. Epub 2023 Jul 7.
引用本文的文献
1
Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study.基因建模的胰高血糖素样肽-1受体（GLP1R）和胃抑制多肽受体（GIPR）激动作用可减少暴饮暴食及与酒精相关的表型：一项多血统药物靶点孟德尔随机化研究
Mol Psychiatry. 2025 Sep 10. doi: 10.1038/s41380-025-03199-3.
2
The Causal Mechanism Between the Dipeptidyl Peptidase-4, Heart Failure, and Other Cardiovascular Diseases: A Mendelian Randomization and Mediation Study.二肽基肽酶-4、心力衰竭及其他心血管疾病之间的因果机制：一项孟德尔随机化与中介研究
Int J Endocrinol. 2025 Aug 26;2025:2357272. doi: 10.1155/ije/2357272. eCollection 2025.
3
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification.跨组织组学引导的药物重新利用确定了阿尔茨海默病新的可靶向机制以及用于治疗分层的候选遗传生物标志物。
Res Sq. 2025 Aug 5:rs.3.rs-7279662. doi: 10.21203/rs.3.rs-7279662/v1.
4
Drug repurposing in amyotrophic lateral sclerosis (ALS).肌萎缩侧索硬化症（ALS）中的药物重新利用。
Expert Opin Drug Discov. 2025 Apr;20(4):447-464. doi: 10.1080/17460441.2025.2474661. Epub 2025 Mar 7.
5
Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges.应用于代谢功能障碍相关脂肪性肝病的药物靶点孟德尔随机化：机遇与挑战
eGastroenterology. 2024 Oct 4;2(4):e100114. doi: 10.1136/egastro-2024-100114. eCollection 2024 Oct.
6
Introduction to Mendelian randomization.孟德尔随机化简介。
Ann Clin Epidemiol. 2025 Jan 1;7(1):27-37. doi: 10.37737/ace.25004.
7
Genetically Proxied Antidiabetic Drug Target and Primary Open-Angle Glaucoma: A Mendelian Randomization Study.基因代理抗糖尿病药物靶点与原发性开角型青光眼：一项孟德尔随机化研究
Health Sci Rep. 2024 Oct 24;7(10):e70162. doi: 10.1002/hsr2.70162. eCollection 2024 Oct.
8
Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target mendelian randomization.在药物靶点孟德尔随机化中，将咖啡因摄入行为与血浆咖啡因水平作为暴露测量指标进行比较。
Am J Epidemiol. 2024 Dec 2;193(12):1776-1784. doi: 10.1093/aje/kwae143.
9
Mendelian randomization for cardiovascular diseases: principles and applications.孟德尔随机化在心血管疾病中的应用：原理与方法。
Eur Heart J. 2023 Dec 14;44(47):4913-4924. doi: 10.1093/eurheartj/ehad736.
本文引用的文献
1
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study.评估二甲双胍靶点降低普通人群阿尔茨海默病风险的疗效和机制：一项孟德尔随机研究。
Diabetologia. 2022 Oct;65(10):1664-1675. doi: 10.1007/s00125-022-05743-0. Epub 2022 Jul 29.
2
Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study.利拉鲁肽而非达格列净或阿卡波糖可增强2型糖尿病患者受损的嗅觉神经激活和认知能力：一项为期16周的随机平行对照研究。
Diabetes Care. 2022 May 1;45(5):1201-1210. doi: 10.2337/dc21-2064.
3
Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer's disease GWAS and self-report proxy phenotype GWAX.孟德尔随机化强调了临床上诊断的阿尔茨海默病 GWAS 和自我报告的代理表型 GWAX 之间存在显著差异和遗传异质性。
Alzheimers Res Ther. 2022 Jan 28;14(1):17. doi: 10.1186/s13195-022-00963-3.
4
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.吡格列酮延迟阿尔茨海默病高危人群认知障碍的安全性和有效性（TOMMORROW）：一项预后生物标志物研究和 3 期、随机、双盲、安慰剂对照试验。
Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0.
5
Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank.中年血管危险因素与痴呆发病风险：英国生物库的纵向队列和孟德尔随机分析。
Alzheimers Dement. 2021 Sep;17(9):1422-1431. doi: 10.1002/alz.12320. Epub 2021 Mar 22.
6
Relationship Between Glycemia and Cognitive Function, Structural Brain Outcomes, and Dementia: A Mendelian Randomization Study in the UK Biobank.血糖与认知功能、脑结构结果及痴呆症之间的关系：英国生物银行的一项孟德尔随机化研究
Diabetes. 2021 Oct;70(10):2313-2321. doi: 10.2337/db20-0895. Epub 2021 Feb 25.
7
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study.利拉鲁肽对比格列美脲对 2 型糖尿病患者认知功能的影响：随机、双盲、活性对照的 CAROLINA-COGNITION 研究结果。
Diabetologia. 2021 Jun;64(6):1235-1245. doi: 10.1007/s00125-021-05393-8. Epub 2021 Feb 9.
8
Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia.遗传中介的白细胞介素 6 受体抑制：与 COVID-19 和肺炎的相反关联。
Eur Respir J. 2021 Jan 14;57(1). doi: 10.1183/13993003.03545-2020. Print 2021 Jan.
9
Glycemic traits and Alzheimer's disease: a Mendelian randomization study.血糖特征与阿尔茨海默病：一项孟德尔随机化研究。
Aging (Albany NY). 2020 Nov 16;12(22):22688-22699. doi: 10.18632/aging.103887.
10
Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome.可改变风险因素与阿尔茨海默病表型之间的因果关联。
Ann Neurol. 2021 Jan;89(1):54-65. doi: 10.1002/ana.25918. Epub 2020 Oct 15.
Zotero 插件